Author

Da-Tong Chu

Observed name: Da‐Tong CHU

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Observed institutions: Chinese University of Hong Kong, Chinese Academy of Medical Sciences & Peking Union Medical College, Guangdong General Hospital, AstraZeneca (Japan), Cancer Hospital of Chinese Academy of Medical Sciences, State Key Laboratory of Oncology in South China, Kindai University

OpenAlex ID: A5110243136

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2009 · Tony S. Mok, Yi-Long Wu, et al. · New England Journal of Medicine · 8,266

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

2011 · Masahiro Fukuoka, Yi-Long Wu, et al. · Journal of Clinical Oncology · 1,582

Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS)

2011 · Sumitra Thongprasert, Emma Duffield, et al. · Journal of Thoracic Oncology · 135

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

2013 · Yi-Long Wu, Masahiro Fukuoka, et al. · Lung Cancer · 47

Phase III, randomized, open‐label, first‐line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non‐small‐cell lung cancer: evaluation of patients recruited from mainland China

2012 · Yi‐Long WU, Da‐Tong CHU, et al. · Asia-Pacific Journal of Clinical Oncology · 47

Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

2007 · Da-Tong Chu, Sang-We Kim, et al. · Lung Cancer · 35

Smoking risks need to be highlighted in Asia

2006 · Da‐Tong CHU · Asia-Pacific Journal of Clinical Oncology

Works count: 7

Citation count: 10,110

H-index: 6

I10-index: 6